![Denis Gravel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Denis Gravel
Director/Board Member at Transdiff, Inc.
Profile
Denis Gravel is the founder of Enobia Pharma, Inc. which was founded in 1997.
Currently, he holds the position of Director at Transdiff, Inc. and Centre de Transmission J.D.H., Inc.
Denis Gravel active positions
Companies | Position | Start |
---|---|---|
Transdiff, Inc.
![]() Transdiff, Inc. Specialty StoresRetail Trade Transdiff, Inc. provides truck dealership services. Its services include transmission, differential, engine, drive shaft, parts, mechanical service, and sale of new and used trucks. The company is headquartered in Quebec, Canada. | Director/Board Member | - |
Centre de Transmission J.D.H., Inc.
![]() Centre de Transmission J.D.H., Inc. Wholesale DistributorsDistribution Services Centre de Transmission J.D.H., Inc. engages in the sale of new trucks and Peterbilt parts and services. The company was founded in 1976 and is headquartered in Quebec, Canada. | Director/Board Member | - |
Former positions of Denis Gravel
Companies | Position | End |
---|---|---|
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Technology |
Transdiff, Inc.
![]() Transdiff, Inc. Specialty StoresRetail Trade Transdiff, Inc. provides truck dealership services. Its services include transmission, differential, engine, drive shaft, parts, mechanical service, and sale of new and used trucks. The company is headquartered in Quebec, Canada. | Retail Trade |
Centre de Transmission J.D.H., Inc.
![]() Centre de Transmission J.D.H., Inc. Wholesale DistributorsDistribution Services Centre de Transmission J.D.H., Inc. engages in the sale of new trucks and Peterbilt parts and services. The company was founded in 1976 and is headquartered in Quebec, Canada. | Distribution Services |
- Stock Market
- Insiders
- Denis Gravel